Porton Pharma Solutions Ltd. (SHE:300363)
China
· Delayed Price · Currency is CNY 21.43
+0.36 (1.71%)
Mar 10, 2026, 10:25 AM CST
Porton Pharma Solutions Revenue
Porton Pharma Solutions had revenue of 923.49M CNY in the quarter ending September 30, 2025, with 19.44% growth. This brings the company's revenue in the last twelve months to 3.43B, up 24.51% year-over-year. In the year 2024, Porton Pharma Solutions had annual revenue of 3.01B, down -17.87%.
Revenue (ttm)
3.43B
Revenue Growth
+24.51%
P/S Ratio
3.32
Revenue / Employee
814.23K
Employees
4,200
Market Cap
11.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.01B | -655.45M | -17.87% |
| Dec 31, 2023 | 3.67B | -3.37B | -47.87% |
| Jan 1, 2023 | 7.03B | 3.93B | 126.55% |
| Jan 1, 2022 | 3.11B | 1.03B | 49.87% |
| Dec 31, 2020 | 2.07B | 520.58M | 33.56% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wanbangde Pharmaceutical Holding Group | 1.39B |
| Mayinglong Pharmaceutical Group | 3.77B |
| Beijing Foyou Pharma CO.,LTD | 3.42B |
| Zhejiang CONBA Pharmaceutical | 6.58B |
| Zhejiang Hisoar Pharmaceutical | 1.86B |
| Zhejiang Hisun Pharmaceutical | 9.84B |
| Henan Lingrui Pharmaceutical | 3.78B |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 5.49B |